Eric Siemers
Technik-/Wissenschafts-/F&E-Leiter bei ACUMEN PHARMACEUTICALS, INC.
Vermögen: 375 067 $ am 30.04.2024
Ursprung des Netzwerks ersten Grades von Eric Siemers
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 25 | |
Huntington Study Group
1
| Non-Profit Organization | 1 | |
BrightFocus Foundation, Inc.
1
| Non-Profit Organization | 1 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Eric Siemers
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Chief Operating Officer General Counsel Chief Tech/Sci/R&D Officer | |
| Yale University | College/University | Doctorate Degree Doctorate Degree | |
RA Capital Management LP
 RA Capital Management LP Investment ManagersFinance RA Capital Management LP (RA Capital) is an independent, SEC-registered investment advisor and hedge fund manager headquartered in Boston, Massachusetts. The firm was founded by Peter Kolchinsky in 2004. RA Capital provides discretionary investment advisory services to Healthcare Funds and the Nexus Funds which are open only to certain financially sophisticated and high net-worth individuals and entities. | Investment Managers | General Counsel Portfolio Manager-Equities | |
Tolerion, Inc.
 Tolerion, Inc. Pharmaceuticals: MajorHealth Technology Tolerion, Inc. operates as a clinical-stage biopharmaceutical firm. It develops and commercializes therapeutics. The firm provides TOL-3034 and TOL-3052 to treat myasthenia gravis and neuromyelitis optica. The company was founded by Lawrence J. Steinman and is headquartered in South San Francisco, CA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| Brown University | College/University | Undergraduate Degree Undergraduate Degree | |
| Baxis Pharmaceuticals, Inc. | Director/Board Member | ||
Biosortia Pharmaceuticals, Inc.
 Biosortia Pharmaceuticals, Inc. BiotechnologyHealth Technology Biosortia Pharmaceuticals, Inc. engages as a researching and developing algal technology company. It focuses on commercialization of concentration, dewatering, drying, and extraction of biomass. The company was founded by Ross O. Youngs in 2008 and is headquartered in Columbus, OH. | Biotechnology | Director/Board Member | |
| AMGEN INC. | Pharmaceuticals: Major | Sales & Marketing | |
| GILEAD SCIENCES, INC. | Biotechnology | Corporate Officer/Principal | |
| University of California, Los Angeles | College/University | Undergraduate Degree | |
| Perelman School of Medicine | College/University | Doctorate Degree | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin | |
| ABBVIE INC. | Pharmaceuticals: Major | Sales & Marketing | |
| ATARA BIOTHERAPEUTICS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Alliance for Regenerative Medicine
 Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services ARM is a Washington, DC-based multi-stakeholder advocacy organization that promotes global initiatives necessary to facilitate access to life-giving advances in regenerative medicine. The organization promotes legislative, regulatory reimbursement, investment, technical, and other initiatives to accelerate the development of safe and effective regenerative medicine technologies. ARM also works to increase public understand- ing of the field and its potential to transform human healthcare. Prior to the formation of ARM in 2009, there was a need for more coordinated and cohesive advocacy representing the interests of the companies, research institutions, investors and patient groups that comprise the entire regenerative medicine community. Today ARM has more than 140 members and is the leading global advocacy organization in this field. | Medical/Nursing Services | Director/Board Member | |
| PASSAGE BIO, INC. | Biotechnology | Director/Board Member | |
F. Hoffmann-La Roche Ltd.
 F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Cellevolve Bio
 Cellevolve Bio Pharmaceuticals: MajorHealth Technology Cellevolve Bio is a company that specializes in the development and commercialization of cell therapies. The company is based in San Francisco, CA. The company's mission is to translate innovation into commercially available treatments to accelerate the revolution in cell therapy. Cellevolve understands that cell therapy innovations require unique and specialized capabilities to advance them to approval and beyond. The company was founded by leaders with extensive experience in developing and launching therapeutics. The company was founded by Derrell D. Porter, who has been the CEO since incorporation. | Pharmaceuticals: Major | Chief Executive Officer | |
Portal Innovations LLC
 Portal Innovations LLC Investment ManagersFinance Portal Innovations LLC (Portal Innovations) is a venture capital firm founded in 2020 by John L. Flavin. The firm is headquartered in Chicago, Illinois. | Investment Managers | Director/Board Member | |
CTRL Therapeutics, Inc.
 CTRL Therapeutics, Inc. BiotechnologyHealth Technology CTRL Therapeutics, Inc. engages in the development of liquid biopsy technology. It focuses on the phenotypic properties of tumors and metastatic disease. The company was founded by Brent Zanke and Shana O. Kelley and is headquartered in Toronto, Canada. | Biotechnology | Chief Executive Officer | |
Sands Capital Ventures LLC
 Sands Capital Ventures LLC Investment ManagersFinance Sands Capital Ventures LLC (Sands Capital Ventures) is a venture capital subsidiary founded in 2010 by Frank Sands. The firm is headquartered in Arlington, Virginia. | Investment Managers | Private Equity Analyst | |
DICE Molecules SV, Inc.
 DICE Molecules SV, Inc. Investment ManagersFinance DICE Molecules SV LLC engages in a biotechnology company. It focuses on the development of small moleculecompounds that act by unlocking protein-protein interfaces that have been intractable targets for orally bioavailable drugs. The company was founded by Pehr Harbury, Kevin Judice, John Bedbrook, and Phil Patten in 2013 and is headquartered in South San Francisco, CA. | Investment Managers | Director/Board Member | |
| DICE THER | Biotechnology | Director/Board Member | |
SeLux Diagnostics, Inc.
 SeLux Diagnostics, Inc. Medical SpecialtiesHealth Technology SeLux Diagnostics, Inc. develops universal synthetic amplifier technology equipment. The firm offers Next Generation Phenotyping (NGP) platform that promises to transform infectious disease patient treatment by dramatically increasing the speed and accuracy with which targeted, personalized antibiotic therapies can be prescribed. The company was founded by Eric Stern and Aleksander Vacic in 2014 and is headquartered in Charlestown, MA. | Medical Specialties | Director/Board Member | |
PTC Therapeutics GT, Inc.
 PTC Therapeutics GT, Inc. Medical SpecialtiesHealth Technology Part of PTC Therapeutics, Inc., PTC Therapeutics GT, Inc. is a company that innovates DNA therapeutics to provide long-term efficacy for patients with debilitating and fatal diseases. The company is based in Lynnfield, MA. The company was founded by Chrystyna Bedrij Stecyk. | Medical Specialties | Corporate Officer/Principal | |
Alzheimer’s Association
 Alzheimer’s Association Miscellaneous Commercial ServicesCommercial Services The Alzheimer's Association is based in Chicago, IL and has subsidiaries in the United States. The Alzheimer's Association provides information and resources for Alzheimer's and other dementias. Alzheimer’s Association was founded in 1980. Joanne Pike has been the CEO of the company since 2016. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Bowdoin College
 Bowdoin College Other Consumer ServicesConsumer Services Bowdoin College is an independent, nonsectarian, coeducational residential, undergraduate liberal arts institution founded in 1794. It is located in Brunswick, ME. | College/University | Undergraduate Degree | |
| Vetana Animal Health, Inc. | Director/Board Member | ||
AstraZeneca Pharmaceuticals AB
 AstraZeneca Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, AstraZeneca Pharmaceuticals AB is a Swedish pharmaceutical company. The company is based in Södertälje, Sweden. The company's description could not be retrieved due to an error. | Pharmaceuticals: Major | Director/Board Member | |
| TAYSHA GENE THERAPIES, INC. | Biotechnology | Director/Board Member | |
| Novartis Gene Therapies Switzerland GmbH | Director/Board Member | ||
PBM Pharmaceuticals, Inc.
 PBM Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology PBM Pharmaceuticals, Inc. manufactures pharmaceutical products. The private company is based in Charlottesville, VA. | Pharmaceuticals: Major | Director/Board Member | |
| University of Massachusetts | College/University | Undergraduate Degree | |
| SAGE THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| University of Delaware | College/University | Undergraduate Degree | |
| Georgetown University | College/University | Doctorate Degree | |
AstraZeneca Pharmaceuticals LP
 AstraZeneca Pharmaceuticals LP Pharmaceuticals: MajorHealth Technology AstraZeneca Pharmaceuticals LP develops, manufactures and markets prescription pharmaceutical drugs. It sells products related to gastrointestinal, cardiovascular, neuroscience, respiratory and oncology infections. The company was founded in 1953 and is headquartered in Wilmington, DE. | Pharmaceuticals: Major | Director/Board Member | |
| Tufts University School of Medicine | College/University | Doctorate Degree | |
| ALKERMES PLC | Pharmaceuticals: Major | Investor Relations Contact | |
| The Leonard N Stern School of Business | College/University | Masters Business Admin | |
| Connecticut College | College/University | Undergraduate Degree | |
| PREVAIL THERAPEUTICS INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
| BIOGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Columbia University College of Physicians & Surgeons | College/University | Corporate Officer/Principal | |
SalioGen Therapeutics, Inc.
 SalioGen Therapeutics, Inc. BiotechnologyHealth Technology SalioGen Therapeutics, Inc. is a genetic medicine company based in Cambridge, MA. The company is advancing the Exact DNA Integration Technology (EDIT) platform, which is a mammal-derived genome engineering technology for use in potentially curative non-viral gene therapy. SalioGen Therapeutics has launched Gene Coding, a genetic medicine technology, to develop durable, broadly applicable genetic medicines using its EDIT platform. The company's mission is to transform the treatment paradigm for patients with inherited disorders. Jason F. Cole has been the CEO of the company since 2023. | Biotechnology | Director/Board Member | |
| Albert Einstein College of Medicine, Inc. | College/University | Corporate Officer/Principal | |
| Washington & Lee University | College/University | Undergraduate Degree | |
NeuroVentures Capital LLC
 NeuroVentures Capital LLC Investment ManagersFinance NeuroVentures Capital LLC (NeuroVenture Capital) is a venture capital firm founded in 1999 by Mark A. Cochran, Daniel J. O'Connell and Hans von Celsing. The firm is headquartered in Charlottesville, Virginia. | Investment Managers | Founder |
Statistik
International
| Vereinigte Staaten | 46 |
| Schweiz | 3 |
| Kanada | 2 |
| Schweden | 2 |
| Irland | 2 |
Sektoral
| Health Technology | 25 |
| Consumer Services | 16 |
| Finance | 7 |
| Health Services | 2 |
| Commercial Services | 2 |
Operativ
| Director/Board Member | 70 |
| Corporate Officer/Principal | 59 |
| Undergraduate Degree | 24 |
| Independent Dir/Board Member | 18 |
| Director of Finance/CFO | 16 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Matthew Zuga | 32 |
| Sean Stalfort | 28 |
| Kimberlee Drapkin | 23 |
| Derrell Porter | 14 |
| Jeffrey Ives | 13 |
| Daniel O'Connell | 11 |
| Stephen Zachary | 10 |
| Laura Stoppel | 9 |
| Jeffrey Sevigny | 9 |
| Derek Meisner | 8 |
| Arvind Sreedharan | 8 |
| Nathan Fountain | 7 |
| Jim Doherty | 6 |
| Grant A. Krafft | 6 |
| Russell Barton | 6 |
- Börse
- Insiders
- Eric Siemers
- Unternehmensverbindungen
